TITLE

Investigating New Antiretroviral Combinations

AUTHOR(S)
Carr, Andrew
PUB. DATE
June 2006
SOURCE
Journal of Infectious Diseases;6/15/2006, Vol. 193 Issue 12, p1742
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Less than the sum of its parts: failure of a tenofovir-abacavir-lamivudine triple-nucleoside regimen," by D.R. Kuritzkes, that was published in a 2005 issue of the "Journal of Infectious Diseases."
ACCESSION #
21175375

 

Related Articles

  • Letter to the Editor: Hypersensitivity Reactions in Patients Treated with Abacavir: Strategies To Avoid Such Reactions. Kapoor, Shailendra // AIDS Patient Care & STDs;Oct2008, Vol. 22 Issue 10, p769 

    A letter to the editor is presented in response to the article "Recent Availability of Two Novel, Fixed Formulations of Antiretroviral Nucleoside Analogues: A 12-Month Prospective, Open-Label Survey of Their Practical Use and Therapeutic Perspectives in Antiretroviral-Naive and Experienced...

  • Allocating Antiretrovirals in South Africa: Using Modeling to Determine Treatment Equity. Wilson, David P.; Blower, Sally M. // PLoS Medicine;Jun2005, Vol. 2 Issue 6, p0563 

    Presents a response by David P. Wilson and Sally M. Blower to a letter to the editor about their article "Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries" in the 2005 issue.

  • Authors' Reply. Capron, Alexander M.; Reis, Andreas // PLoS Medicine;Jun2005, Vol. 2 Issue 6, p0564 

    Presents a letter to the editor in response to the article "Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries," by David P. Wilson and Sally M. Blower in the 2005 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Messori, Andrea; Trippoli, Sabrina; Vaiani, Monica // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A letter to the editor is presented in response to an article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Laurence, Jeffrey // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A letter to the editor is presented in response to an article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Freedberg, Kenneth A.; Losina, Elena; Goldie, Sue J. // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A esponse by Kenneth A. Freedberg et al. to a letter to the editor about their article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue is presented.

  • Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. Thorne, Claire; Fiore, Simona; Rudin, Christoph // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p471 

    A letter to the editor is presented in response to the article "Antiretroviral Therapy During Pregnancy and the Risk of an Adverse Outcome" in the June 13, 2002 issue.

  • Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. Tuomala, Ruth E.; Shapiro, David E.; Mofenson, Lynne M. // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p471 

    A response by Ruth E. Tuomala and colleagues to a letter to the editor about their article "Antiretroviral Therapy During Pregnancy and the Risk of an Adverse Outcome" in the June 13, 2002 issue is presented.

  • The AIDS Pandemic. Reynolds, Steven J.; Quinn, Thomas C.; Bollinger, Robert C. // New England Journal of Medicine;8/21/2003, Vol. 349 Issue 8, p814 

    A response by Steven J. Reynolds et al. to a letter to the editor about their article "Antiretroviral Therapy Where Resources Are Limited," in the May 1, 2003 issue is presented.

  • Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis. Mena, Álvaro; Vázquez, Pilar; Castro, Ángeles; López, Soledad; Bello, Laura; Pedreira, José D. // Journal of Antimicrobial Chemotherapy (JAC);Apr2011, Vol. 66 Issue 4, p951 

    A letter to the editor is presented in response to the article "Clinical Experience of Raltegravir-containing Regimens in HIV-infected Patients During Rifampicin-containing Treatment of Tuberculosis."

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics